Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01161992 · ClinicalTrials.gov registry record
Genomics of Primary Sclerosing Cholangitis (PSC)
A clinical trial of Primary Sclerosing Cholangitis (PSC), sponsored by Mayo Clinic.
- Completed
- Registry status
- 1,500
- Enrollment target
- 1
- Study location
NCT01161992 is a study of Primary Sclerosing Cholangitis (PSC) that has completed, run by Mayo Clinic. The registered enrollment target is 1,500 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01161992, a study of Primary Sclerosing Cholangitis (PSC), has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
- 1
- Study location
Study Summary
Primary Sclerosing Cholangitis (PSC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PSC. This study is being done to investigate whether genes make people more likely to develop PSC. Discovery of these genes will help us to better understand how PSC developes and subsequently, to apply new approaches for its prevention, diagnosis and treatment.
Conditions Studied
Interventions
- GENETIC Genetic Analysis
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2002-03 |
| Est. Completion | 2025-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01161992
The ClinicalTrials.gov registry entry for NCT01161992 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Primary Sclerosing Cholangitis (PSC) appearing as the primary indexed condition, and to 1 intervention - of which Genetic Analysis is the first listed.
NCT01161992 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01161992 about?
NCT01161992 is a clinical study titled "Genomics of Primary Sclerosing Cholangitis (PSC)". Primary Sclerosing Cholangitis (PSC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PSC. This study is being done...
What is the current status of trial NCT01161992?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2002-03. Estimated completion is 2025-07-31.
What conditions does trial NCT01161992 study?
This clinical trial studies the following conditions: Primary Sclerosing Cholangitis (PSC).
What interventions are being tested in trial NCT01161992?
The interventions under investigation include: Genetic Analysis (GENETIC).
Who is sponsoring clinical trial NCT01161992?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01161992 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Sclerosing Cholangitis (PSC)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.